Clinical Impact of FORCETM Platform in Duchenne

Please join us during our Community Webinar Series on April 17th as we welcome the team from Dyne Therapeutics to speak on updates to the DELIVER trial of DYNE-251 in males with Duchenne mutations amenable to exon 51 skipping. Clinical Impact of FORCETM Platform in Duchenne April 17, 2025 | 1pm ET| Zoom

Community Webinar: Cardiac Devices

Tune in to hear from Andreas Barth on cardiac devices in Duchenne, Becker, and Carrier patients with an emphasis on implanted devices.